NASDAQ · Financial Statements

Replimune Group, Inc. (REPL) Financial Statements

$11.46 NASDAQ: REPL Market Cap $1.08B

Replimune Group, Inc. most recently reported annual revenue of $0, a net loss of $314.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Replimune Group, Inc.: net profit was positive in 0 of 10 reported years; the most recent year shows a net loss of $314.0M.

Income Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Revenue$0$0$0$0$0$0$0$0$0$0
Operating Expenses$10.0M$19.0M$31.0M$56.0M$83.0M$121.0M$177.0M$235.0M$262.0M$320.0M
Operating Profit$-10.0M$-19.0M$-31.0M$-56.0M$-83.0M$-121.0M$-177.0M$-235.0M$-262.0M$-320.0M
Operating Margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Other Income$2.0M$0$0$4.0M$-1.0M$0$3.0M$19.0M$15.0M$5.0M
Interest$0$0$0$2.0M$3.0M$2.0M$4.0M$7.0M$8.0M$9.0M
Depreciation$0$0$0$1.0M$4.0M$5.0M$2.0M$5.0M$6.0M$3.0M
Profit Before Tax$-8.0M$-20.0M$-31.0M$-53.0M$-84.0M$-121.0M$-174.0M$-215.0M$-247.0M$-314.0M
Tax$0$0$0$0$3.4M$2.6M$-170,000$-190,000$-190,000$180,000
Net Profit$-8.0M$-20.0M$-31.0M$-53.0M$-81.0M$-118.0M$-174.0M$-216.0M$-247.0M$-314.0M
EPS$-0.25$-0.64$-1.33$-1.54$-1.75$-2.26$-2.99$-3.24$-3.07$-3.38
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$0$0$0$0$0$0$0$0$0$0$0$0
Operating Expenses$64.0M$57.0M$59.0M$57.0M$59.0M$66.0M$80.0M$90.0M$84.0M$72.0M$73.0M$68.0M
Operating Profit$-64.0M$-57.0M$-59.0M$-57.0M$-59.0M$-66.0M$-80.0M$-90.0M$-84.0M$-72.0M$-73.0M$-68.0M
Operating Margin0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Interest$1.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$2.0M$1.0M$2.0M$4.0M$3.0M
Profit Before Tax$-60.0M$-51.0M$-55.0M$-54.0M$-53.0M$-66.0M$-75.0M$-87.0M$-83.0M$-71.0M$-73.0M$-70.0M
Tax$330,000$-930,000$120,000$0$0$-870,000$880,000$0$0$440,000$330,000$420,000
Net Profit$-60.0M$-51.0M$-55.0M$-54.0M$-53.0M$-66.0M$-74.0M$-87.0M$-83.0M$-71.0M$-73.0M$-70.0M
EPS$-0.90$-0.77$-0.90$-0.78$-0.68$-0.79$-0.96$-0.95$-0.90$-0.77$-0.76$-0.72

Over the 10 years reported for Replimune Group, Inc., cash stood at $209.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 4.81 times.

Balance Sheet — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Total Assets$23.0M$65.0M$154.0M$234.0M$543.0M$461.0M$647.0M$488.0M$551.0M$332.0M
Current Assets$22.0M$65.0M$141.0M$174.0M$484.0M$404.0M$593.0M$434.0M$496.0M$279.0M
Cash$21.0M$18.0M$26.0M$60.0M$183.0M$106.0M$147.0M$74.0M$111.0M$209.0M
Inventory$0$0$0$0$0$0$0$0$0$0
Receivables$1.0M$2.0M$2.0M$3.0M$3.0M$3.0M$3.0M$5.0M$4.0M$2.0M
Fixed Assets$0$0$12.0M$58.0M$58.0M$56.0M$52.0M$52.0M$53.0M$49.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$44.0M$110.0M$109.0M$294.0M$290.0M$437.0M$346.0M$373.0M$60.0M
Other Assets$0$0$0$0$0$0$0$0$0$0
Total Liabilities$34.0M$93.0M$16.0M$50.0M$44.0M$50.0M$91.0M$113.0M$135.0M$166.0M
Current Liabilities$2.0M$5.0M$10.0M$12.0M$15.0M$21.0M$34.0M$40.0M$62.0M$58.0M
Borrowings$0$0$7.0M$42.0M$33.0M$33.0M$61.0M$76.0M$76.0M$112.0M
Other Liabilities$34.0M$93.0M$10.0M$9.0M$11.0M$17.0M$31.0M$37.0M$59.0M$55.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$-12.0M$-28.0M$138.0M$184.0M$499.0M$411.0M$555.0M$375.0M$416.0M$166.0M

For Replimune Group, Inc., operating cash flow was positive in 0 of 10 reported years; free cash flow in the latest year was negative at $285.0M; free cash flow was positive in 0 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2017201820192020202120222023202420252026
Operating Cash Flow$-7.0M$-16.0M$-25.0M$-61.0M$-61.0M$-82.0M$-128.0M$-185.0M$-192.0M$-280.0M
Investing Cash Flow$0$-88.0M$-132.0M$-12.0M$-191.0M$-4.0M$-145.0M$92.0M$-30.0M$307.0M
Financing Cash Flow$0$0$-2.0M$28.0M$97.0M$0$96.0M$0$97.0M$0
Net Cash Flow$6.0M$-3.0M$9.0M$34.0M$123.0M$-77.0M$41.0M$-72.0M$37.0M$98.0M
Free Cash Flow$-7.0M$-16.0M$-28.0M$-67.0M$-64.0M$-85.0M$-130.0M$-191.0M$-199.0M$-285.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.69
EV / EBITDA-3.52
FCF Yield-25.55%
Quick Ratio5.23
Interest Coverage-31.46
Return 1Y213.64%
Return 3Y-50.64%
Return 5Y-69.32%

Replimune Group, Inc. (REPL) financials — frequently asked questions

What is Replimune Group, Inc.'s annual revenue?

Replimune Group, Inc. (REPL) reported annual revenue of $0 in its most recent fiscal year.

What is Replimune Group, Inc.'s net profit?

Replimune Group, Inc. (REPL) reported a net loss of $314.0M in its most recent fiscal year.

What is REPL EV/EBITDA?

Replimune Group, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -3.52. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
REPL Overview REPL Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.